Molina Healthcare, Inc 8-K, filed Oct 21, 2026

Molina Healthcare, Inc. (MOH)

8-K 2026-10-21 For: 2026-10-21

Added on October 22, 2026

About this 8-K

Molina Healthcare, Inc filed this 8-K on October 21, 2026.

Molina Healthcare, Inc. reported third quarter 2026 GAAP diluted EPS of $0.73 and adjusted diluted EPS of $0.89, and reaffirmed full-year 2026 premium revenue guidance of approximately $42 billion and adjusted EPS of at least $5.25. AI summary

Items reported

Item 2.02: Financial results
Item 9.01: Financial statements and exhibits

Search and read filings like this one from Claude or ChatGPT with the SEC filings MCP server →


Delaware	1-31719	13-4204626
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)


200 Oceangate, Suite 100,	Long Beach,	California	90802
(Address of principal executive offices)			(Zip Code)


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 Par Value	MOH	New York Stock Exchange


Exhibit No.			Description
99.1			Press release of Molina Healthcare, Inc., issued October 21, 2026.
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)


		MOLINA HEALTHCARE, INC.

Date:	October 21, 2026	By:	/s/ Jeff D. Barlow
			Jeff D. Barlow
			Chief Legal Officer and Secretary


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.
			☐


	Three months ended				Nine months ended
	September 30,				September 30,
	2026		2025		2026		2025

(In millions, except per-share results)
Premium Revenue	$10,457		$10,841		$30,873		$32,337
Total Revenue	$11,082		$11,477		$32,752		$34,051

GAAP:
Net Income	$38		$79		$112		$632
EPS – Diluted	$0.73		$1.51		$2.19		$11.79
Medical Care Ratio (MCR)	92.9	%	92.6	%	92.1	%	90.8	%
G&A Ratio	6.4	%	6.4	%	6.8	%	6.5	%
Pre-tax Margin	0.5	%	0.8	%	0.5	%	2.4	%

Adjusted:
Net Income	$46		$97		$243		$724
EPS – Diluted	$0.89		$1.84		$4.74		$13.49
G&A Ratio	6.3	%	6.3	%	6.6	%	6.4	%
Pre-tax Margin	0.6	%	1.0	%	1.1	%	2.7	%

See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release.


	September 30,		December 31,
	2026		2025
	Unaudited
	(Dollars in millions, except per-share amounts)
ASSETS
Current assets:
Cash and cash equivalents	$	4,479	$	4,248
Investments	4,100		4,008
Receivables	3,359		3,533
Prepaid expenses and other current assets	576		655
Total current assets	12,514		12,444
Property, equipment, and capitalized software, net	324		301
Goodwill and intangible assets, net	2,073		2,195
Restricted investments	345		299
Deferred income taxes, net	267		178
Other assets	129		147
Total assets	$	15,652	$	15,564

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Medical claims and benefits payable	$	4,988	$	4,887
Amounts due government agencies	1,141		1,326
Accounts payable, accrued liabilities and other	1,183		1,093
Deferred revenue	82		66
Total current liabilities	7,394		7,372
Long-term debt	3,771		3,766
Finance lease liabilities	179		184
Other long-term liabilities	153		173
Total liabilities	11,497		11,495
Stockholders’ equity:
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 52 million shares at September 30, 2026, and 51 million at December 31, 2025	—		—
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding	—		—
Additional paid-in capital	536		452
Accumulated other comprehensive (loss) income	(95)		15
Retained earnings	3,714		3,602
Total stockholders’ equity	4,155		4,069
Total liabilities and stockholders’ equity	$	15,652	$	15,564






















	Three Months Ended September 30,
	2026						2025
	Premium Revenue		Medical Margin		MCR (1)		Premium Revenue		Medical Margin		MCR (1)

Medicaid	$	8,199	$	577	93.0	%	$	8,015	$	639	92.0	%
Medicare	1,616		113		93.0		1,610		103		93.6
Marketplace	642		48		92.5		1,197		53		95.6
Other (2)	—		—		NM		19		2		NM
Consolidated	$	10,457	$	738	92.9	%	$	10,841	$	797	92.6	%






















	Nine Months Ended September 30,
	2026						2025
	Premium Revenue		Medical Margin		MCR (1)		Premium Revenue		Medical Margin		MCR (1)

Medicaid	$	24,175	$	1,793	92.6	%	$	24,174	$	2,127	91.2	%
Medicare	4,698		413		91.2		4,686		436		90.7
Marketplace	1,994		233		88.3		3,401		411		87.9
Other (2)	6		5		NM		76		11		NM
Consolidated	$	30,873	$	2,444	92.1	%	$	32,337	$	2,985	90.8	%

(1)The MCR represents medical costs as a percentage of premium revenue.
(2) The Other MCRs are not meaningful.


	Amount		Per Diluted Share (2)
GAAP Net income	$	122	$	2.38
Adjustments:
Acquisition-related expenses	48		0.89
Amortization of intangible assets	36		0.70
Impairment	93		1.82
Other	21		0.44
Subtotal, adjustments	198		3.85
Income tax effect (1)	(50)		(0.98)
Adjustments, net of tax	148		2.87
Adjusted net income	$	270	$	5.25


Emerging growth company			☐


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2026		2025		2026		2025

	(In millions, except per-share amounts)
Revenue:
Premium revenue	$	10,457	$	10,841	$	30,873	$	32,337
Premium tax revenue	500		506		1,509		1,325


Investment income	102		108		301		322
Other revenue	23		22		69		67
Total revenue	11,082		11,477		32,752		34,051
Operating expenses:
Medical care costs	9,719		10,044		28,429		29,352
General and administrative expenses	710		729		2,213		2,214
Premium tax expenses	500		506		1,509		1,325

Depreciation and amortization	38		45		117		151
Impairment	—		—		93		—
Other	9		16		57		66
Total operating expenses	10,976		11,340		32,418		33,108
Operating income	106		137		334		943

Interest expense	53		49		161		140


Income before income tax expense	53		88		173		803
Income tax expense	15		9		61		171
Net income	$	38	$	79	$	112	$	632

Net income per share – Diluted	$	0.73	$	1.51	$	2.19	$	11.79

Diluted weighted average shares outstanding	51.5		52.5		51.3		53.6


	Nine Months Ended
	September 30,
	2026		2025

	(In millions)
Operating activities:
Net income	$	112	$	632
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	117		151
Deferred income taxes	(54)		37
Share-based compensation	85		27

Impairment	93		—
Other, net	(21)		(2)
Changes in operating assets and liabilities:
Receivables	174		(118)
Prepaid expenses and other current assets	11		(25)
Medical claims and benefits payable	101		(157)
Amounts due government agencies	(185)		(467)
Accounts payable, accrued liabilities and other	88		(195)
Deferred revenue	16		(44)
Income taxes	92		(76)
Net cash provided by (used in) operating activities	629		(237)
Investing activities:
Purchases of investments	(1,245)		(607)
Proceeds from sales and maturities of investments	1,020		1,017
Purchases of property, equipment, and capitalized software	(94)		(102)
Net cash paid in business combinations	—		(245)
Other, net	(9)		19
Net cash (used in) provided by investing activities	(328)		82
Financing activities:
Proceeds from borrowings under credit facility and term loans	—		1,100
Common stock purchases	—		(1,000)
Repayment of credit facility and term loans	—		(360)


Common stock withheld to settle employee tax obligations	(15)		(37)


	September 30,	December 31,	September 30,
	2026	2025	2025
Ending Membership by Segment:
Medicaid	4,372,000	4,568,000	4,639,000
Medicare	222,000	262,000	266,000
Marketplace	267,000	655,000	713,000
Other	1,000	6,000	10,000
Total	4,862,000	5,491,000	5,628,000